The plasma p-tau181 we assessed, correlates better with amyloid pathology than tau pathology on PET-imaging [36] and also has weaker associations with tau pathology on neuropathological examination as compared to CSF p-tau181 [37]. The gene discussed is MAPT; the disease is amyloidosis.